Every time ABT is on its way back to 50, it gets clobbered. The stock gets raves from analysts and is considered less likely to be hurt by Obama's policies than other big pharmas, and yet the pattern persists. Why? And when this stock get the support it deserves?
It doesn't mean it should go down either. Stocks should trade on the basis of their fundamentals--products, management, ranking in the space, etc. ABT is a leader among the big pharmas, yet it is treated like a laggard for no discernible reason.
Jakstat or whatever,how about P___E. All stocks are probably overpriced do to that organism that headed the country for the last 8 years. He took us to the edge of the event horizon. The bicycle story was O.K. but nothing great. Now, say something good about ABT. Phy
Jak, Count me out as one of the "idiots" on this board.
Most everyone on this board likely has some retail holding of, or "position in" ABT. That is well and good. Beyond this though ABT requires special handling. In other words, over the last 6 weeks where the market indices have been attempting to trend HIGHER, one can easily correlate how the "market" handles ABT specially. Don't fight the tape.